NCT03272984

ERAS for Patients Received Neoadjuvant Chemotherapy

Enhanced Recovery After Surgery Programs for Patients Received Neoadjuvant Chemotherapy With Locally Advanced Gastric Cancer: a Randomized Controlled Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 114 (actual)
• Sponsor: JIANG Zhi-Wei · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Patients received neoadjuvant chemotherapy with locally advanced gastric caner undergo the enhanced recovery after surgery (ERAS) programs or the standard cares (SC) programs.

Detailed description

Before, most trials about the ERAS for radical gastrectomy demonstrated ERAS programs accelerate the postoperative rehabilitation of gastric cancer patients without increasing postoperative complications. However, in most trials, patients who received neoadjuvant chemotherapy were excluded. The investigators designed this trial for patients received neoadjuvant chemotherapy. In this trial, patients received neoadjuvant chemotherapy with locally advanced gastric caner undergo the ERAS programs or the SC programs. Finally, the investigators evaluated whether patients who receive neoadjuvant chemotherapy can be enrolled into the ERAS programs for locally advanced gastric cancer.

Conditions

• Gastric Cancer

Interventions

Type	Name	Description
PROCEDURE	ERAS group	ERAS is the name of a procedure. Patients in this group need receive the ERAS procedure instead of one drug.
PROCEDURE	SC group	Patients were managed in accordance with SC programs during the perioperative period. SC programs were used daily in our center and were still routinely used in most of the other hospitals in China.

Timeline

• Start date: 2015-04-01
• Primary completion: 2017-06-05
• Completion: 2017-07-06
• First posted: 2017-09-06
• Last updated: 2017-09-08

Locations

1 site across 1 country: China